Literature DB >> 23964996

Who benefits from treatment for executive dysfunction after brain injury? Negative effects of emotion recognition deficits.

Jacoba M Spikman1, Danielle H E Boelen, Gerdina H M Pijnenborg, Marieke E Timmerman, Joukje van der Naalt, Luciano Fasotti.   

Abstract

Deficits in emotion recognition, a crucial aspect of social cognition, are common after serious brain injury, as are executive deficits. Since social cognition and executive function are considered to be separate constructs, our first aim was to examine the presence of emotion recognition problems in brain injury patients with dysexecutive problems. We studied 65 brain injury patients of mixed aetiology participating in a randomised controlled trial evaluating the effects of a multifaceted treatment for executive dysfunction (Spikman, Boelen, Lamberts, Brouwer, & Fasotti, 2010 ) and 84 matched controls with a test for emotion recognition. Results showed that, in patients with acquired brain injury exhibiting executive deficits, emotion recognition deficits are also present. Male patients are more impaired than female patients, irrespective of aetiology. Our second aim was to investigate whether emotion recognition problems negatively predict the results of the treatment programme. Pre-treatment emotion recognition performance significantly predicted resumption of roles in daily life (Role Resumption List; RRL) and performance on an ecologically valid test for everyday executive functioning (Executive Secretarial Task; EST) post-treatment and, in addition, interfered negatively with treatment condition. Moreover, worse pre-treatment emotion recognition skills affect the learning of compensatory strategies for executive dysfunction negatively, whereas pre-treatment dysexecutive deficits do not.

Entities:  

Mesh:

Year:  2013        PMID: 23964996     DOI: 10.1080/09602011.2013.826138

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  8 in total

1.  Impaired theory of mind in adults with traumatic brain injury: A replication and extension of findings.

Authors:  L S Turkstra; R S Norman; B Mutlu; M C Duff
Journal:  Neuropsychologia       Date:  2018-01-31       Impact factor: 3.139

2.  Facial-affect recognition deficit as a predictor of different aspects of social-communication impairment in traumatic brain injury.

Authors:  Arianna Rigon; Lyn S Turkstra; Bilge Mutlu; Melissa C Duff
Journal:  Neuropsychology       Date:  2018-05       Impact factor: 3.295

3.  Functional neural correlates of facial affect recognition impairment following TBI.

Authors:  Arianna Rigon; Michelle W Voss; Lyn S Turkstra; Bilge Mutlu; Melissa C Duff
Journal:  Brain Imaging Behav       Date:  2019-04       Impact factor: 3.978

4.  Labelling Facial Affect in Context in Adults with and without TBI.

Authors:  Lyn S Turkstra; Sarah G Kraning; Sarah K Riedeman; Bilge Mutlu; Melissa Duff; Sara VanDenHeuvel
Journal:  Brain Impair       Date:  2016-12-13       Impact factor: 1.727

5.  Predicting caregiver burden over the first 4 months after acute traumatic brain injury in Latin America: a multi-country study.

Authors:  Mickeal Pugh; Paul B Perrin; Juan Carlos Arango-Lasprilla
Journal:  Brain Inj       Date:  2021-04-06       Impact factor: 2.167

6.  Long-Term Use and Perceived Benefits of Goal-Oriented Attentional Self-Regulation Training in Chronic Brain Injury.

Authors:  Fred Loya; Tatjana Novakovic-Agopian; Deborah Binder; Annemarie Rossi; Scott Rome; Michelle Murphy; Anthony J-W Chen
Journal:  Rehabil Res Pract       Date:  2017-02-07

7.  Relationship between individual differences in functional connectivity and facial-emotion recognition abilities in adults with traumatic brain injury.

Authors:  A Rigon; M W Voss; L S Turkstra; B Mutlu; M C Duff
Journal:  Neuroimage Clin       Date:  2016-12-12       Impact factor: 4.881

8.  Comparing static and dynamic emotion recognition tests: Performance of healthy participants.

Authors:  Sara Khosdelazad; Lieke S Jorna; Skye McDonald; Sandra E Rakers; Rients B Huitema; Anne M Buunk; Jacoba M Spikman
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.